Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2012

May 4, 2012

284_dirs_2012-05-04_c1b26fc5-378d-45e8-974d-e500961f306f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2012-05-02

Reporting Person: Heller Bridgette P (Exe.VP & Pres.Con.Hlth.Care)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-05-02 Restricted Stock Unit $ A 5599.0000 Acquired 2015-05-02 Common Stock (5599.0000) Direct
2012-05-02 Stock Option (right to buy) $39.2900 A 80439.0000 Acquired 2022-05-01 Common Stock (80439.0000) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F2: The option vests in three equal annual installments beginning May 2, 2013.